Criteo wraps up first leg of redomiciliation as board greenlights U.S. move and NYSE listing
CRTO sits 40% above its 52-week low of $15.575.
Summary
Criteo completed its redomiciliation from France to Luxembourg and its board approved the final step to the U.S., expected January 2027, with a planned NYSE listing. The move aims to enhance shareholder value and index inclusion but requires shareholder approval.
Key Events · Corporate Governance and Compliance · CRTO
-
Redomiciliation Step 1 Complete
Effective July 29, 2026, Criteo transferred its legal domicile from France to Luxembourg, terminating its ADS program and converting ADSs to ordinary shares that now trade directly on Nasdaq.
-
Board Approves U.S. Move
The board approved the second step — a cross-border merger into a U.S. subsidiary — which is expected to complete in January 2027, subject to shareholder approval.
-
NYSE Listing Planned
Upon establishing a U.S. domicile, Criteo intends to move its listing from Nasdaq to the NYSE, citing the exchange's index advisory capabilities and the potential for major index inclusion.
-
Strategic Rationale
The redomiciliation aims to reduce corporate complexity, increase capital management flexibility, and attract a broader investor base, including passive funds.
Analysis · CRTO · Trade & Services
Marking a pivotal milestone in its long-planned redomiciliation, Criteo has completed the transfer of its legal domicile from France to Luxembourg. The board has now approved the second and final step — a move to the United States, expected in January 2027 — and intends to list on the NYSE. This is a material corporate governance event that could broaden the shareholder base and improve index eligibility, but it remains subject to shareholder approval and carries execution risk. The move comes amid a recent takeover offer from Vista Equity and Quinti Capital at a significant premium, adding strategic context.
At the time of this filing, CRTO was trading at $21.80 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $15.58 to $26.53. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.